Surveillance based on molecular epidemiology for Haemophilus influenzae isolates between 1998 and 2000 in Japan

Japanese Journal of Chemotherapy

Volumn 50, Issue 11, 2002, Pages 794-804

  Ubukata, Kimiko ^a   Hasegawa, Keiko ^a   Chiba, Naoko ^b   Kobayashi, Reiko ^b   Konno, Masatoshi ^c  

^a KITASATO UNIVERSITY   (Japan)

^b MEIJI SEIKA KAISHA LTD   (Japan)

^c TEIKYO UNIVERSITY   (Japan)

Author keywords

lactamase nonproducing ampicillin rsistance; Haemophilus influenzae; Surveillance; Susceptibility of lactam antibiotics

Indexed keywords

AMINO ACID; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; ASPARAGINE; BACTERIAL PROTEIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFACLOR; CEFCAPENE; CEFDINIR; CEFDITOREN; CEFOTAXIME; CEFOTIAM; CEFOZOPRAN; CEFPODOXIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; FROPENEM; IMIPENEM; LEVOFLOXACIN; LYSINE; MEMBRANE PROTEIN; MEROPENEM; PANIPENEM; PIPERACILLIN; PRIMER DNA; SERINE; UNINDEXED DRUG;

ADULT; AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BRONCHITIS; CHILD; CLASSIFICATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; GENE MUTATION; GENETIC ANALYSIS; HAEMOPHILUS INFLUENZAE; HUMAN; IMMUNITY; JAPAN; MINIMUM INHIBITORY CONCENTRATION; OTITIS MEDIA; PENICILLIN RESISTANCE; PNEUMONIA; POLYMERASE CHAIN REACTION; PREVALENCE; PROTEIN MOTIF; SCHOOL; UPPER RESPIRATORY TRACT INFECTION;

EID: 0036858760     PISSN: 13407007     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Japanese source - PRSP, BLNAR - JJ Antibiotics 52 (Suppl. B): 4-13, 1998
2. Japanese source ampicillin Haemophilus influenzae Chemotherapy 26: 491-498, 1978
3. Japanese source Haemophilus influenzae Haemophilus influenzae Chemotherapy 26: 508-516, 1978
4. Vega R H, Sadoff L, Pafferson M J: Mechanism of ampicillin resistant in haemophilus influenzae type b. antimicrob Agents Chemother 9: 164-168, 1976
5. Mendelman P M, Chaffin D O, Stull T, et al.: Characterization of non-β-lactamase-mediated ampicillin resistance in Haemophilus influenzae. Antimicrob Agents Chemother 26: 235-244, 1984
6. Parr T R Jr, Bryan L E: Mechanism of resistance of an ampicillin-resistant, β-lactamase-negative clinical isolate of Haemophilus type b to β-lactam antibiotics. Antimicrob Agents Chemother 25: 747-753, 1984
7. Mendelman P M, Chaffin D O, Musser J M, et al.: Genetic and phenotypic divesity among ampicillin-resistant, non-β-lactamase-producing, nontypeable Haemophilus influenzae isolates. Infect Immun 55: 2585-2589, 1987
8. Ubukata K, Shibasaki Y, Yamamoto K, et al.: Association of amino acid substitutions in penicillin-binding protein 3 with β-lactam resistance in β-lactamase-negative ampicillin-resistant Haemophilus influenzae. Animicrob Agents Chemother 45: 1693-1699, 2001
9. Clairoux N, Picard M, Brochu A, et al.: Molecular basis of the non-β-lactamase-mediated resistance to β-lactam antibiotics in strains of Haemophilus influenzae isolated in Canada. Antimicrob Agents Chemother 36: 1504-1513, 1992
10. Powell M, Yeo S F, Seymour A, et al.: Antimicrobial resistance in Haemophilus influenzae from England and Scotland in 1991. J Antimicrob Chemother 29: 547-554, 1992
11. Jorgensen J H: Update on mechanisms and prevalence of antimicrobial resistance in Haemophilus influenzae. Clin Infect Dis 14: 1119-1123, 1992
12. Barry A L, Fuchs P C, Pfaller M A: Susceptibilities of β-lactamase-producing and -nonproducing ampicillin-resistant strains of Haemophilus influenzae to ceftibuten, cefaclor, cefuroxime, cefixime, cefotaxime, and amoxicillin-clavulanic acid. Antimicrob Agents Chemother 37: 14-18, 1993
13. Doern G V, Brueggemann A B, Pierce G, et al.: Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of β-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study. Antimicrob Agents Chemother 41: 292-297, 1997
14. Richter S S, Brueggemann A B, Huynh H K, et al.: A 1997-1998 national surveillance study: Moraxella catarrhalis and Haemophilus influenzae antimicrobial resistance in 34 US institutions. Int J Antimicrob Agents 13: 99-107, 1999
15. Nelson M B, Apicella M A, Murphy T F, et al.: Cloning and sequencing of haemophilus influenzae outer membrane protein P 6. Infect Immun 56: 128-134, 1998
16. National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial susceptibility testing. Fifth informational supplement M 100-S 10. Villanova P A: National Committee for Clinical Laboratory Standards: 2000
17. Japanese source 1999
18. Japanese source -PRSP, BLNAR - 2 J J Antibiotics 54 (Suppl. B): 72-79, 2001
19. Japanese source Cefditoren pivoxil 49: 369-396, 2001
20. Ubakata K, Chiba N, Hasegawa K, et al.: differentiation of β-lactamase-negative ampicillin-resistant Haemophilus influenzae from other H. influenzae strains by a disc method. J infect Chemother 8: 50-58, 2002
21. Dabernat H, Delmas C, Seguy M, et al.: Diversity of β-lactam resistance-conferring amino acid substitutions in penicillin-binding protein 3 of Haemophilus influenzae Antimicrob Agents Chemother 46: 2208-2218, 2002
22. Schoendorf K C, Adams W G, Kiely J L, et al.: National trends in Haemophilus influenzae meningitis mortality and hospitalization among children, 1980 through 1991. Pediatrics 93: 663-668, 1994
23. Japanese source Haemophilus influenzae Ampicillin Haemophilus influenzea Chemotherapy 26: 666-675, 1978